Drawing for ZEPTALZA

USPTO serial 86808265

ZEPTALZA

Reviewed by CopyMark Law Group

Reg. 5011578Status 710
Filing date
Status date
Registration date
Aug 2, 2016
Examiner
LOVELACE, JAMES B
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ZEPTALZA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia A. Smith

CLAUDIA A. SMITH WHITE & CASE LLP1155 AVENUE OF THE AMERICASTRADEMARK DEPARTMENTNEW YORK, NY 10036

Goods and services

ClassDescriptionStatusFirst use
005Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; medical diagnostic preparations for medical purposes, reagents for medical use, diagnostic agents preparations and substances for medical purposesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 17, 2023C8..CANCELLED SEC. 8 (6-YR)—
Aug 2, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 2, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 17, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 17, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 27, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 14, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 4, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 30, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 30, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 23, 2016ALIEASSIGNED TO LIE—
Mar 9, 2016ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 22, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 22, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Jan 22, 2016CNSLSUSPENSION LETTER WRITTEN—
Jan 22, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jan 22, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 22, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 22, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 21, 2016DOCKASSIGNED TO EXAMINER—
Nov 6, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 6, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance